GridAI Technologies (GRDX) Interest Coverage Ratio (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Interest Coverage Ratio came in at 45.88 in Q1 2025, up 66.62% on a YoY basis from 27.54 in Q1 2024, and down 100.56% quarter-over-quarter from 8264.66 in Q3 2024.
Powered by 
Analysis
GridAI Technologies (GRDX) Interest Coverage Ratio (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has reported Interest Coverage Ratio for 11 consecutive years, with 45.88 the latest figure, recorded in Q1 2025.
- For the quarter ending Q1 2025, Interest Coverage Ratio rose 66.62% year-over-year to 45.88; the trailing twelve-month figure through Mar 2025 stood at 87.78 (up 65.6% YoY), and the FY2023 full-year result was 702.08, up 12.07% from the prior year.
- Interest Coverage Ratio declined to 45.88 in Q1 2025 per GRDX's latest filing, from 8264.66 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 15716.09 in Q2 2024 and bottomed at 40969.65 in Q3 2021.
- Historically, Interest Coverage Ratio has averaged 1893.78 across 5 years, with a median of 646.45 in 2023.
- The sharpest annual moves came in 2021 and 2024: Interest Coverage Ratio plunged 1328130.43% in 2021, then jumped 1969.03% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 4662.62 in 2021, then soared by 92.11% to 368.1 in 2022, then decreased by 18.88% to 437.59 in 2023, then surged by 1988.69% to 8264.66 in 2024, then plunged by 100.56% to 45.88 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 45.88, 8264.66, and 15716.09 for Q1 2025, Q3 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -45.88 |
| Sep 30, 2024 | 8,264.66 |
| Jun 30, 2024 | 15,716.09 |
| Mar 31, 2024 | -137.44 |
| Dec 31, 2023 | -437.59 |
| Sep 30, 2023 | -3,362.52 |
| Jun 30, 2023 | -840.87 |
| Mar 31, 2023 | -452.03 |
| Dec 31, 2022 | -368.10 |
| Sep 30, 2022 | 5,086.36 |
| Jun 30, 2022 | -1,679.88 |
| Mar 31, 2022 | -1,673.88 |
| Dec 31, 2021 | -4,662.62 |
| Sep 30, 2021 | -40,969.65 |
| Jun 30, 2021 | -3,140.45 |
| Mar 31, 2021 | -1,596.72 |
| Dec 31, 2020 | -7,919.29 |
| Sep 30, 2020 | -3.08 |
| Jun 30, 2020 | -1.04 |
| Mar 31, 2020 | -1.26 |